232 related articles for article (PubMed ID: 10646729)
1. A multicenter trial of specific local nasal immunotherapy.
Motta G; Passali D; De Vincentiis I; Ottaviani A; Maurizi M; Sartoris A; Pallestrini E; Motta S; Salzano FA
Laryngoscope; 2000 Jan; 110(1):132-9. PubMed ID: 10646729
[TBL] [Abstract][Full Text] [Related]
2. Low-dose local nasal immunotherapy in children with perennial allergic rhinitis due to Dermatophagoides.
Marcucci F; Sensi LG; Caffarelli C; Cavagni G; Bernardini R; Tiri A; Riva G; Novembre E
Allergy; 2002 Jan; 57(1):23-8. PubMed ID: 11991284
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and tolerability of a steady dosage schedule of local nasal immunotherapy. Results of preseasonal treatment in grass pollen rhinitis.
Bertoni M; Cosmi F; Bianchi I; Di Berardino L
Ann Allergy Asthma Immunol; 1999 Jan; 82(1):47-51. PubMed ID: 9988206
[TBL] [Abstract][Full Text] [Related]
4. [The results of extra diagnostic methods in patients allergic to dust mites treated by specific immunotherapy].
Modrzyński M; Mazurek H; Zawisza E
Przegl Lek; 2005; 62(12):1337-42. PubMed ID: 16786743
[TBL] [Abstract][Full Text] [Related]
5. Nasal immunotherapy in weed-induced allergic rhinitis.
Gaglani B; Borish L; Bartelson BL; Buchmeier A; Keller L; Nelson HS
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):259-65. PubMed ID: 9305235
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of nasal immunotherapy to Parietaria: clinical and local immunological effects.
Passalacqua G; Albano M; Pronzato C; Riccio AM; Scordamaglia A; Falagiani P; Canonica GW
Clin Exp Allergy; 1997 Aug; 27(8):904-8. PubMed ID: 9291287
[TBL] [Abstract][Full Text] [Related]
7. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus.
Tsai JJ; Liao EC; Tsai FH; Hsieh CC; Lee MF
J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124
[TBL] [Abstract][Full Text] [Related]
8. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
[TBL] [Abstract][Full Text] [Related]
9. Short-term efficacy of nasal immunotherapy.
Palma-Carlos AG; Santos AS; Pregal A
Allerg Immunol (Paris); 1998 Jan; 30(1):14-7. PubMed ID: 9503098
[TBL] [Abstract][Full Text] [Related]
10. Nasal application of immunotherapy.
Ascione E; De Lucia A; Imperiali M; Varricchio A; Motta G
Chem Immunol Allergy; 2003; 82():89-98. PubMed ID: 12947995
[TBL] [Abstract][Full Text] [Related]
11. Specific local nasal immunotherapy: Single center experience on 324 patients.
Scarpa A; De Luca P; Marra P; Bisogno A; Salzano G; Ricciardiello F; Capasso P; Romano D; Viola P; Ralli M; Di Stadio A; Salzano FA
Am J Otolaryngol; 2023; 44(2):103694. PubMed ID: 36473264
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S
Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
[TBL] [Abstract][Full Text] [Related]
13. Intranasal immunotherapy with Dermatophagoides extract: in vivo and in vitro results of a double-blind placebo-controlled trial.
Fanales-Belasio E; Ciofalo A; Zambetti G; Ansotegui IJ; Scala E; Paganelli R; Filiaci F
Rhinology; 1995 Sep; 33(3):126-31. PubMed ID: 8560161
[TBL] [Abstract][Full Text] [Related]
14. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
15. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
[TBL] [Abstract][Full Text] [Related]
16. Specific nasal provocation test with powder allergen.
Salzano FA
Allergy; 1997; 52(33 Suppl):32-5. PubMed ID: 9188946
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immunotherapy by nasal antigen challenge.
Cengizlier R; Saraçlar Y; Tomaç N
J Otolaryngol; 1999 Aug; 28(4):185-8. PubMed ID: 10461254
[TBL] [Abstract][Full Text] [Related]
18. Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation.
Passalacqua G; Albano M; Ruffoni S; Pronzato C; Riccio AM; Di Berardino L; Scordamaglia A; Canonica GW
Am J Respir Crit Care Med; 1995 Aug; 152(2):461-6. PubMed ID: 7633693
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study.
Tari MG; Mancino M; Monti G
Allergol Immunopathol (Madr); 1990; 18(5):277-84. PubMed ID: 2097894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
